Data-Driven Technology Roadmaps to Identify Potential Technology Opportunities for Hyperuricemia Drugs.

ABSTRACT: Hyperuricemia is a metabolic disease with an increasing incidence in recent years. It is critical to identify potential technology opportunities for hyperuricemia drugs to assist drug innovation. A technology roadmap (TRM) can efficiently integrate data analysis tools to track recent technology trends and identify potential technology opportunities. Therefore, this paper proposes a systematic data-driven TRM approach to identify potential technology opportunities for hyperuricemia drugs. This data-driven TRM includes the following three aspects: layer mapping, content mapping and opportunity finding. First we deal with layer mapping.. The BERT model is used to map the collected literature, patents and commercial hyperuricemia drugs data into the technology layer and market layer in TRM. Th

SUBMITTER: Feng L 

PROVIDER: S-EPMC9694917 | biostudies-literature | 2022 Nov

REPOSITORIES: biostudies-literature